Quick Links

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit

PER® designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Credit

Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-9999-16-083-H01-P. The activity is available for CE credit through June 27, 2017.

Instructions for Completing the Activity and Receiving Continuing Pharmacy Education (CPE) Credit

To receive CPE credit, pharmacist participants must log onto where you will be directed to the activity pre-test. Participants must complete the pretest, read the article in its entirety, and complete the online evaluation and posttest with a score of 70% or better before the activity expires. After successful completion and submission of the online posttest and activity evaluation, your credit will be uploaded to CPE Monitor™. You may view your credit within 48 hours at

NOTE: All steps must be completed in order to receive credit. Please ensure that your Pharmacy Times account is updated with your NABP e-profile number and your date of birth (MMDD format). Participation data will not be uploaded into CPE Monitor™ if you do not have your NABP e-profile number and date of birth entered into your profile on


PER Pulse ™ Recaps
highlight key elements of the Oncology Consultations®: Identifying Best Practices of the Multidisciplinary Team in CINV Management online CME activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from, Eisai Inc., Merck Sharp & Dohme Corp. and Tesaro, Inc.

Oncology Consultations®: Identifying Best Practices of the Multidisciplinary Team in CINV Management

Release Date: June 28, 2016
Expiration Date: June 28, 2017
Estimated Time to Complete Activity:
2 hours
Media: Internet-based

Activity Overview

This activity will use the PER® Oncology Consultations® format, a series of four consultations between a medical oncologist and a pharmacist, including lively discussions around guideline-consistent care, novel therapeutic agents, barriers to effective management, and the role of the multi-disciplinary team in patient center care, in an effort to improve patient outcomes. The discussions will also place relevant information presented at recent society meetings into clinical context.

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational initiative is directed toward physicians and clinical pharmacists including those in specialty, hospital-based and health-system pharmacy settings, involved in the care of patients who currently receive cancer therapy and are at risk for or encountering CINV. Other health care professionals with an interest in managing CINV will also be invited to participate.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:
  • Review optimal use of antiemetic regimens for CINV and benefits of providing guideline-consistent care.
  • Compare the safety and efficacy of new antiemetic strategies for CINV with established regimens.
  • Identify strategies for managing challenging situations, such as breakthrough symptoms, delayed CINV, nausea, and providing antiemetic regimens for multi-day chemotherapy.
  • Examine how a multidisciplinary approach to patient education, communication, and ongoing assessment of CINV response can improve outcomes in CINV.

Faculty, Staff, and Planners' Disclosures


Richard Gralla, MD, FACP
Professor of Medicine
Albert Einstein College of Medicine
Jacobi Medical Center
Bronx, New York
Disclosure: Consultant: Merck, Tesaro, Helsinn, Eisai; Other Support: Honoraria: Merck, Helsinn, Eisai

Sally Yowell Barbour, PharmD, BCOP, CPP
Director of Oncology Pharmacy Programs
PGY2 Oncology Residency Director
Clinical Pharmacist Practitioner
Department of Pharmacy
Duke Uinversity Hospital
Durham, North Carolina
Disclosure: Other Support: Travel support for presentation: Tesaro.

The following individuals have no relevant financial relationships with commercial interests:

The planning staff of PER® and PTCE™ (Dave Heckard; Mary Jo Dixon, RPh; PharmD, RPh; Donna Fausak).

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians' Education Resource®, LCC (PER®), and Pharmacy Times Continuing Education™ (PTCE™) to ensure the fair balance, independence, objectivity, and scientific rigor in all of our CME/CPE activities. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE) guidelines, PER® and PTCE™ require everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® and PTCE™ have implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME/CPE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CPE activity is for continuing medical education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, and/or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® and PTCE™, or the company that provided commercial support for this activity.

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

CME Provider Contact Information

Physicians' Education Resource®, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Toll-free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705

Pharmacy CE Provider Contact Information

Pharmacy Times Continuing Education™
666 Plainsboro Road, Suite 425
Plainsboro, NJ 08536
Toll-free: 800-597-6372



Become a Member

Forgot Password?
Filter By